PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
21726410-6	2011	The C(max) and AUC(inf) of 5"-hydroxylornoxicam were lower in CYP2C9*1/*13 individuals than in CYP2C9*1/*1 individuals, but the half-life of 5"-hydroxylornoxicam did not differ between the two groups.	5'-hydroxylornoxicam	27-47	cytochrome P450 family 2 subfamily C member 9	Homo sapiens	62-68
21726410-6	2011	The C(max) and AUC(inf) of 5"-hydroxylornoxicam were lower in CYP2C9*1/*13 individuals than in CYP2C9*1/*1 individuals, but the half-life of 5"-hydroxylornoxicam did not differ between the two groups.	5'-hydroxylornoxicam	27-47	cytochrome P450 family 2 subfamily C member 9	Homo sapiens	95-101
21726410-9	2011	A CYP2C9*1/*13 genotype markedly reduced the conversion of lornoxicam to 5"-hydroxylornoxicam, to a similar extent as that observed with the CYP2C9*1/*3 genotype.	5'-hydroxylornoxicam	73-93	cytochrome P450 family 2 subfamily C member 9	Homo sapiens	2-8
21726410-9	2011	A CYP2C9*1/*13 genotype markedly reduced the conversion of lornoxicam to 5"-hydroxylornoxicam, to a similar extent as that observed with the CYP2C9*1/*3 genotype.	5'-hydroxylornoxicam	73-93	cytochrome P450 family 2 subfamily C member 9	Homo sapiens	141-147